Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday . The stock traded as low as C$0.16 and last traded at C$0.17, with a volume of 598249 shares trading hands. The stock had previously closed at C$0.18.
Nanalysis Scientific Stock Down 8.3%
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The stock has a market cap of C$18.95 million, a price-to-earnings ratio of -1.50 and a beta of -0.82. The business’s 50 day moving average is C$0.19 and its 200 day moving average is C$0.22.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Read More
- Five stocks we like better than Nanalysis Scientific
- Upcoming IPO Stock Lockup Period, Explained
- Missed the AI Boom? These 2 Crushed Stocks Could Be Your Second Chance
- What is the Nasdaq? Complete Overview with History
- A New Leader at Six Flags: Is the Roller Coaster Over?
- Stock Splits, Do They Really Impact Investors?
- 3 Reasons Baidu Could Be the Dark Horse of Global AI
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
